PTC Therapeutics | PTCT - Pre Tax Profit

Stock Price
74.68
Daily Change
2.32 3.21%
Monthly
-3.31%
Yearly
50.96%
Q1 Forecast
73.20

PTC Therapeutics reported $-23.07M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 44.6M 4.38M Sep/2025
Alnylam Pharmaceuticals USD 238.97M 274.33M Sep/2025
Amgen USD 3.92B 2.35B Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Cytokinetics USD -306.18M 171.81M Sep/2025
Daiichi Sankyo JPY 106.73B 48.96B Dec/2025
Gilead Sciences USD 2.43B 780M Jun/2025
Incyte USD 482.31M 75.7M Sep/2025
Ionis Pharmaceuticals USD -129M 253M Sep/2025
Ironwood Pharmaceuticals USD 68.02M 30.2M Sep/2025
Novartis USD 4.2B 335M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
PTC Therapeutics USD -23.07M 47.98M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sarepta Therapeutics USD -194.05M 347.69M Sep/2025
TG Therapeutics USD 25.91M 5.01M Sep/2025
Ultragenyx Pharmaceutical USD -179.54M 65.54M Sep/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025
Xencor USD -6.03M 25.05M Sep/2025